Venn Life Sciences client win
08 November 2012
Walbrook PR are pleased to announce its appointment as Financial PR advisor to Armscote Investment Company Plc, to manage communications with the financial media, research analysts and investors surrounding its acquisition of Venn Life Sciences Ltd, Placing to raise £2.5m and admission to AIM.
.jpg "Fusion Antibodies - Landscape (Trimmed)")
.png "MyHealthChecked PLC_Logo_2 Line_Colour_Red_RGB_AW (003)"){kind=logo}
